Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2010
11/11/2010US20100285568 Recombinant factor x with no glycosylation and method for preparing the same
11/11/2010US20100285567 Tat signal peptides for producing proteins in prokaryotes
11/11/2010US20100285566 has superior thermal stability and is obtained by culturing a microorganism belonging to the genus Burkholderia; biosensor for measuring and analyzing glucose concentration of fluids diabetes;
11/11/2010US20100285565 Escherichia coli expressing the cytochrome p-450 gene and a method for microbial conversion using them
11/11/2010US20100285564 Anticalins
11/11/2010US20100285562 Isocyclomaltooligosaccharide(s), isocyclomaltooligosaccharide-forming enzyme, their preparation and uses
11/11/2010US20100285557 Efficient Astaxanthin Production Strains Derived from Haematococcus Pluvialis
11/11/2010US20100285547 New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design
11/11/2010US20100285545 Biosynthetic routes to long-chain alpha,omega-hydroxyacids, diacids and their conversion to oligomers and polymers
11/11/2010US20100285544 Novel aminotransferase, gene encoding the same, and method of using them
11/11/2010US20100285543 Novel Endophytic Fungi And Methods Of Use
11/11/2010US20100285541 Transaminase biocatalysts
11/11/2010US20100285540 Process for the preparation of (R)-Beta-Arylalanines by coupled Racemase/Aminomutase catalysis
11/11/2010US20100285538 Methods for nucleic acid manipulation
11/11/2010US20100285536 Method and apparatus for amplification of nucleic acid sequences by using thermal convection
11/11/2010US20100285532 Production of heterologous proteins or peptides
11/11/2010US20100285530 E.Coli Host Cells with Modified Phos/Psts Periplasmic Phosphate-binding Proteins, and Method of Manufacturing Recombinant Fabs
11/11/2010US20100285529 Feline granulocyte macrophage colony stimulating factor proteins
11/11/2010US20100285528 Method, vector and system for expressing polypeptides
11/11/2010US20100285527 Novel Polypeptide, cDNA Encoding the Same, and Use Thereof
11/11/2010US20100285526 Compositions and Methods for Fusion Protein Separation
11/11/2010US20100285499 HUMAN p51 GENES AND GENE PRODUCTS THEREOF
11/11/2010US20100285484 Apoptosis inducing positive control for expression modulation experiments
11/11/2010US20100285482 Methods for nucleic acid manipulation
11/11/2010US20100285481 Methods for nucleic acid manipulation
11/11/2010US20100285475 Fused genes
11/11/2010US20100285464 A conserved region of the hiv-1 genome and uses thereof
11/11/2010US20100285457 High-Throughput Diagnostic Assay For the Human Virus Causing Severe Acute Respiratory Syndrome (SARS)
11/11/2010US20100285448 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
11/11/2010US20100285445 Chimeric construct of mungbean yellow mosaic india virus (mymiv) and its uses thereof
11/11/2010US20100285202 Soybean Cultivar S080206
11/11/2010US20100285173 Glucose-induced inactivation/degradation-resistant transporter gene and use thereof
11/11/2010US20100285132 Immunotherapy compositions, method of making and method of use thereof
11/11/2010US20100285131 Fgf21 mutants and uses thereof
11/11/2010US20100285111 Self-assembling micelle-like nanoparticles for systemic gene delivery
11/11/2010US20100285109 Truncated secretory aspartyl proteinase 2
11/11/2010US20100285104 Compositions and methods for the delivery of oxygen
11/11/2010US20100285073 a micro-rna family that modulates fibrosis and uses thereof
11/11/2010US20100285070 Polynucleotides of haemophilus parasuis and its use
11/11/2010US20100285068 Method for the internalization of non-invasive bacteria in eukaryote cells
11/11/2010US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
11/11/2010US20100285048 Use of flagellin in the immunotherapy of yersinia pestis
11/11/2010US20100285045 Novel Neurotrophic Factor Protein and Uses Thereof
11/11/2010US20100285043 Mite antigenic rice
11/11/2010US20100285038 Factor Involved in Metastasis and Uses Thereof
11/11/2010US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
11/11/2010US20100285035 High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1
11/11/2010US20100285027 Antibodies specific for human hepcidin
11/11/2010US20100285023 Detecting cyp24 expression level as a marker for predisposition to cancer
11/11/2010US20100285017 Matriptase protein and uses thereof
11/11/2010US20100285014 Immunoglobulin fusion proteins
11/11/2010US20100285009 Humanized anti-egfl7 antibodies and methods using same
11/11/2010US20100285004 Anti-CD38 human antibodies and uses thereof
11/11/2010US20100284995 Temperature sensitive mutants of matrix metalloproteases and uses thereof
11/11/2010US20100284990 Compositions and Methods for Making Therapies Delivered by Viral Vectors Reversible for Safety and Allele-Specificity
11/11/2010US20100284977 Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters
11/11/2010US20100284975 Polypeptides comprising fas activation and nkg2d-ligand domains
11/11/2010US20100284971 Modified factor viii and factor ix genes and vectors for gene therapy
11/11/2010US20100284961 MCP-1 binding nucleic acids
11/11/2010US20100284959 Sequence specific double-stranded dna/rna binding compounds and uses thereof
11/11/2010US20100284920 Uses of monoclonal antibody 8h9
11/11/2010US20100284918 Protein
11/11/2010US20100284916 Antibodies Against Human Cytomegalovirus (HCMV)
11/11/2010US20100284910 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers
11/11/2010US20100284909 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
11/11/2010US20100284907 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells
11/11/2010US20100282634 Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis
11/11/2010CA2838400A1 Humanized anti-egfl7 antibodies and methods using same
11/11/2010CA2761614A1 Human fg01 gene and its applications
11/11/2010CA2761435A1 Increasing protein production by increasing abc50 expression or activity
11/11/2010CA2761411A1 Microrna expression profiling and targeting in chronic obstructive pulmonary disease (copd) lung tissue and methods of use thereof
11/11/2010CA2761310A1 Antibodies and methods of use thereof
11/11/2010CA2761248A1 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
11/11/2010CA2761203A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
11/11/2010CA2761183A1 Oncolytic adenoviruses for treating cancer
11/11/2010CA2761152A1 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
11/11/2010CA2761142A1 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
11/11/2010CA2761106A1 Lipophilic polynucleotide conjugates
11/11/2010CA2760890A1 Anti-cd100 antibodies and methods for using the same
11/11/2010CA2760883A1 Prevention and treatment of nosema disease in bees
11/11/2010CA2760876A1 Novel sugar transporters
11/11/2010CA2760787A1 Combined measles-malaria vaccine
11/11/2010CA2760754A1 Plants having enhanced yield-related traits and/or enhanced abiotic stress tolerance and a method for making the same
11/11/2010CA2760700A1 Yield enhancement in plants by modulation of ap2 transcription factor
11/11/2010CA2760310A1 Compositions and methods for enhancing antigen-specific immune responses
11/11/2010CA2760246A1 Humanized anti-egfl7 antibodies and methods using same
11/11/2010CA2760155A1 Real-time sequencing methods and systems
11/11/2010CA2760153A1 Reagents and methods for producing bioactive secreted peptides
11/11/2010CA2759801A1 Gene therapy for neurodegenerative disorders
11/11/2010CA2759602A1 Cho /cert cell lines
11/10/2010EP2248914A1 The use of class IIB restriction endonucleases in 2nd generation sequencing applications
11/10/2010EP2248910A1 Epitope synchronization in antigen presenting cells
11/10/2010EP2248906A1 Method of producing l-amino acid
11/10/2010EP2248903A1 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
11/10/2010EP2248902A2 Precise breeding
11/10/2010EP2248901A1 Streptogramines and method for preparing same by mutasynthesis
11/10/2010EP2248900A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
11/10/2010EP2248899A1 NOGO receptor binding protein
11/10/2010EP2248898A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/10/2010EP2248897A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
1 ... 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 ... 4023